THC's fourth-quarter results are likely to reflect growing patient admissions, utilization and patient days.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Get a deeper insight into the potential performance of Tenet (THC) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Tenet Healthcare (THC) closed the most recent trading day at $143.71, moving -0.64% from the previous trading session.
Tenet (THC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The latest trading day saw Tenet Healthcare (THC) settling at $139.67, representing a +0.56% change from its previous close.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Tenet Healthcare (THC) concluded the recent trading session at $134.42, signifying a -0.01% move from its prior day's close.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
In the most recent trading session, Tenet Healthcare (THC) closed at $127.63, indicating a -1.27% shift from the previous trading day.